Kyle A. Romine
Impact in
-
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
Papers in
-
- Protein Degradation and Inhibitors 3
- Histone Deacetylase Inhibitors Research 1
- Melanoma and MAPK Pathways 1
-
- Acute Myeloid Leukemia Research 3
- Chronic Myeloid Leukemia Treatments 1
- Multiple Myeloma Research and Treatments 1
- Co-authors
- Daniel Bottomly (4 shared papers)Jeffrey Tyner (3 shared papers)Shannon K. McWeeney (4 shared papers)Ravindra Majeti (2 shared papers)Andy Kaempf (2 shared papers)M. Ryan Corces (1 shared paper)Sophia Jeng (1 shared paper)Yoko Kosaka (2 shared papers)
- Journals
- Blood (2 papers)British Journal of Haematology (2 papers)Blood Advances (1 paper)Frontiers in Oncology (1 paper)Leukemia (1 paper)
- Partner nations
- United StatesIndiaGermany
In The Last Decade
Kyle A. Romine
8 papers receiving 86 citations
Peers
Comparison fields: 5 of 26
- Hematology 40
- Biological Psychiatry 3
- Immunology 22
- Genetics 10
- Oncology 18
Countries citing papers authored by Kyle A. Romine
This map shows the geographic impact of Kyle A. Romine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle A. Romine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle A. Romine more than expected).
Fields of papers citing papers by Kyle A. Romine
This network shows the impact of papers produced by Kyle A. Romine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle A. Romine. The network helps show where Kyle A. Romine may publish in the future.
Co-authors
The 25 scholars most cited alongside Kyle A. Romine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 24 | |
| 2 | 2021 | 23 | |
| 3 | 2023 | 18 | |
| 4 | 2019 | 14 | |
| 5 | 2022 | 3 | |
| 6 | 2025 | 2 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 1 |
About Kyle A. Romine
Kyle A. Romine is a scholar working on Molecular Biology, Hematology, Genetics, Oncology and Rheumatology, having authored 8 papers that have together received 86 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Protein Degradation and Inhibitors (3 papers), Chronic Myeloid Leukemia Treatments (1 paper), Cancer Genomics and Diagnostics (1 paper), Histone Deacetylase Inhibitors Research (1 paper), Hemoglobinopathies and Related Disorders (1 paper), Melanoma and MAPK Pathways (1 paper) and Multiple Myeloma Research and Treatments (1 paper). The work is most often cited by research in Hematology (40 citations), Biological Psychiatry (3 citations), Immunology (22 citations), Genetics (10 citations) and Oncology (18 citations). Kyle A. Romine has collaborated with scholars based in United States, India and Germany. Frequent co-authors include Daniel Bottomly, Jeffrey Tyner, Shannon K. McWeeney, Ravindra Majeti, Andy Kaempf, M. Ryan Corces, Sophia Jeng, Yoko Kosaka, Tamilla Nechiporuk and Evan Lind. Their work appears in journals such as Blood, British Journal of Haematology, Blood Advances, Frontiers in Oncology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.